Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 10/20 | 0.35 |
| ▸ | CNR1 | P21554 | 8/20 | 0.35 |
| ▸ | PPARD | Q03181 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | RARB | P10826 | 3/20 | 0.32 |
| ▸ | RARA | P10276 | 1/20 | 0.32 |
| ▸ | RARG | P13631 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19796609 | 0.92 | CNR2 (0.38) | CNR2CNR1TSHRCA1CA2 | |
| SCHEMBL19797003 | 0.91 | CNR2 (0.34) | CNR2CNR1TSHRRARBRARA | |
| SCHEMBL19797012 | 0.90 | PPARD (0.37) | CNR2CNR1PPARDTSHRRARB | |
| SCHEMBL19797007 | 0.90 | CA1 (0.32) | PPARDTSHRRARBRARARARG | |
| SCHEMBL19797002 | 0.90 | CYP3A4 (0.35) | CNR2CNR1PPARDRARBRARA | |
| SCHEMBL19797020 | 0.89 | CNR2 (0.35) | CNR2CNR1PPARDTSHRRARB | |
| SCHEMBL19801966 | 0.89 | S1PR1 (0.37) | RARBRARARARGCA1CA2 | |
| SCHEMBL19796980 | 0.88 | TSHR (0.33) | PPARDTSHRRARBCA1CA2 | |
| SCHEMBL19796611 | 0.88 | CNR2 (0.35) | CNR2CNR1TSHRCA1CA2 | |
| SCHEMBL19797087 | 0.88 | SPHK1 (0.37) | TSHRRARBFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, C1S, AP3D1 | CNR2 1075/4885CNR1 320/4885PPARD 3071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.